Results from HIVEC-II for Intermediate-risk Non-muscle-invasive Bladder Cancer: Is This a Dead End for Mitomycin C
Clara Cerrato1, Morgan Roupret2, Maria Carmen Mir3
1Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
European Urology
|March 26, 2023
Abstract
No abstract available in PubMed .


